A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Compass Pathways PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 25,400 shares of CMPS stock, worth $216,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,400
Previous 65,500 61.22%
Holding current value
$216,915
Previous $559,000 61.36%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
N/A
2,291,324 Added 146.41%
3,856,324 $32.9 Million
Q4 2023

Feb 14, 2024

SELL
N/A
-856 Reduced 0.05%
1,565,000 $13.4 Million
Q3 2023

Nov 14, 2023

BUY
N/A
1,565,856 New
1,565,856 $13.4 Million
Q1 2023

May 15, 2023

SELL
$7.32 - $10.85 $1.22 Million - $1.81 Million
-167,172 Reduced 94.94%
8,918 $88,000
Q4 2022

Feb 14, 2023

BUY
$7.84 - $11.68 $236,619 - $352,514
30,181 Added 20.68%
176,090 $1.41 Million
Q3 2022

Nov 14, 2022

SELL
$10.73 - $20.07 $975,013 - $1.82 Million
-90,868 Reduced 38.38%
145,909 $1.57 Million
Q2 2022

Aug 15, 2022

SELL
$6.76 - $14.18 $90,969 - $190,820
-13,457 Reduced 5.38%
236,777 $2.56 Million
Q1 2022

May 16, 2022

SELL
$11.13 - $23.04 $2.58 Million - $5.35 Million
-232,163 Reduced 48.13%
250,234 $3.23 Million
Q4 2021

Feb 14, 2022

BUY
$21.81 - $48.96 $9.2 Million - $20.6 Million
421,726 Added 695.1%
482,397 $10.7 Million
Q3 2021

Nov 15, 2021

SELL
$29.03 - $38.62 $321,507 - $427,716
-11,075 Reduced 15.44%
60,671 $1.81 Million
Q2 2021

Aug 16, 2021

SELL
$32.29 - $39.68 $1.22 Million - $1.5 Million
-37,709 Reduced 34.45%
71,746 $2.74 Million
Q1 2021

May 17, 2021

BUY
$34.75 - $57.5 $993,294 - $1.64 Million
28,584 Added 35.35%
109,455 $4.03 Million
Q4 2020

Feb 16, 2021

SELL
$32.0 - $59.2 $6.57 Million - $12.2 Million
-205,283 Reduced 71.74%
80,871 $3.85 Million
Q3 2020

Nov 16, 2020

BUY
$28.83 - $43.17 $8.25 Million - $12.4 Million
286,154 New
286,154 $9.99 Million

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.